Higgons John Duncan 4
4 · Jounce Therapeutics, Inc. · Filed Jan 8, 2020
Insider Transaction Report
Form 4
Higgons John Duncan
Director
Transactions
- Sale
Common Stock
2020-01-06$8.11/sh−1,500$12,165→ 12,013 total
Footnotes (2)
- [F1]The transaction reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 6, 2019. The Reporting Person exercised no discretion with respect to this transaction.
- [F2]Total adjusted by the transfer of 13,512 shares in a transaction exempt under Rule 16a-12.